XEROS TECHNOLOGY GROUP PLC Logo

XEROS TECHNOLOGY GROUP PLC

Develops and licenses polymer-based solutions that reduce industrial water consumption.

XSG | IL

Overview

Corporate Details

ISIN(s):
GB00BMGYBJ57
LEI:
2138009F3U39GVY7DG06
Country:
United Kingdom
Address:
UNIT 2, EVOLUTION ADVANCED MANUFACTURING PARK, S60 5BL ROTHERHAM

Description

Xeros Technology Group is a platform technology company that develops and licenses patented, polymer-based solutions designed to reduce the environmental impact of water-intensive industrial and commercial processes. The company's core technologies significantly decrease water and energy consumption in applications across the laundry, apparel manufacturing, and textile care industries. Key products derived from its platform include advanced laundry care systems, denim finishing systems that reduce chemical and water usage, and microfibre filtration systems that capture harmful microplastics released during washing cycles. Xeros licenses its innovations to manufacturers for integration into commercial and domestic appliances.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 14:20
TR-1 Entrepreneurs Fund
English 33.7 KB
2025-12-02 18:00
TR-1 Lombard Odier
English 50.9 KB
2025-12-02 15:40
TR-1 Dowgate
English 20.9 KB
2025-12-02 12:20
TR-1 Maven
English 21.0 KB
2025-11-28 12:15
Results of General Meeting and Director Dealings
English 43.3 KB
2025-11-27 13:40
Result of Follow-on Subscription and TVR
English 18.8 KB
2025-11-26 17:55
TR-1 Spreadex
English 22.3 KB
2025-11-11 14:25
Result of Retail Offer
English 26.4 KB
2025-11-07 11:25
Result of Fundraising
English 25.6 KB
2025-11-07 08:20
Retail Offer
English 40.7 KB
2025-11-06 19:45
Proposed Fundraise
English 279.1 KB
2025-10-24 16:07
Block listing Interim Review
English 14.2 KB
2025-10-14 18:11
TR-1 Maven
English 22.1 KB
2025-10-10 18:20
TR-1 Dowgate
English 22.0 KB
2025-10-09 15:05
TR-1 Spreadex
English 23.5 KB

Automate Your Workflow. Get a real-time feed of all XEROS TECHNOLOGY GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for XEROS TECHNOLOGY GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for XEROS TECHNOLOGY GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KAZIA THERAPEUTICS LTD Logo
Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.
United States of America
KZIA
Keros Therapeutics, Inc. Logo
Develops protein therapeutics for disorders linked to TGF-β signaling.
United States of America
KROS
Kura Oncology, Inc. Logo
Clinical-stage biopharma company developing precision medicines for cancer treatment.
United States of America
KURA
Larimar Therapeutics, Inc. Logo
A clinical-stage biotech developing treatments for complex rare diseases.
United States of America
LRMR
Lexaria Bioscience Corp. Logo
A biotech company with a patented platform to improve oral drug delivery and absorption.
United States of America
LEXX
LigaChem Biosciences Inc. Logo
Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.
South Korea
141080
Linical Co., Ltd. Logo
A global CRO providing a full spectrum of drug development services for biopharma.
Japan
2183
Lipigon Pharmaceuticals AB Logo
A clinical-stage company developing therapeutics for lipid-related disorders.
Sweden
LPGO
Lipum AB Logo
Clinical-stage biopharma developing novel treatments for chronic inflammatory diseases.
Sweden
LIPUM
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage pharma company developing PP2A inhibitors to enhance cancer therapies.
United States of America
LIXT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.